| Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. |
2020-03-31 |
| AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. |
2020-03-31 |
| BioNTech SE. (3/31/20). "Press Release: BioNTech Announces Full Year 2019 Financial Results and Corporate Update". Mainz. |
2020-03-31 |
| InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. |
2020-03-31 |
| Danaher Corporation. (3/31/20). "Press Release: Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences, Business Will Be Called Cytiva". Washington, DC. |
2020-03-31 |
| Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge. |
2020-03-30 |
| ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA. |
2020-03-30 |
| H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby. |
2020-03-27 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer". |
2020-03-27 |
| SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA. |
2020-03-26 |
| ReCode Therapeutics. (3/26/20). "Press Release: ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing". Menlo Park, CA & Dallas, TX. |
2020-03-26 |
| Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. |
2020-03-26 |
| Forge Therapeutics, Inc.. (3/25/20). "Press Release: Forge Enters into Collaboration with Roche to Develop Novel Antibiotic to Treat Lung Infections". San Diego, CA. |
2020-03-25 |
| ProBioGen AG. (3/24/20). "Press Release: Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services". Berlin & Houston, TX. |
2020-03-24 |
| Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. |
2020-03-24 |
| Codexis, Inc.. (23/3/20). "Press Release: Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders". Redwood City, CA. |
2020-03-23 |
| AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. |
2020-03-23 |
| Genedata AG. (3/23/20). "Press Release: CytomX Therapeutics Deploys Genedata Bioprocess". South San Francisco, CA & Tokyo. |
2020-03-23 |
| CytomX Therapeutics, Inc.. (3/23/20). "Press Release: CytomX Therapeutics Announces Appointment of Carlos Campoy as Chief Financial Officer". South San Francisco, CA. |
2020-03-23 |
| Back Bay Life Science Advisors. (23/3/20). "Press Release: Transaction Update. Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders". |
2020-03-23 |
| CytomX Therapeutics, Inc.. (3/23/20). "Press Release: CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody T-Cell Engaging Bispecific Therapies for Treatment of Cancer". South San Francisco, CA & Tokyo. |
2020-03-23 |
| Cepheid. (21/3/20). "Press Release: Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test". Sunnyvale, CA. |
2020-03-21 |
| Eppendorf AG. (3/19/20). "Press Release: Eppendorf Acquires Centrifuge Business of Koki Holdings Co., Ltd.". Hamburg & Tokyo. |
2020-03-19 |
| Oxford BioMedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. |
2020-03-18 |
| Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY. |
2020-03-18 |
| Oxford BioMedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford. |
2020-03-18 |
| AGC Inc.. (3/17/20). "Press Release: AGC Decides to Launch Volunatry Tender Offer for Shares of MolMed". |
2020-03-17 |
| Sigilon Therapeutics, Inc.. (3/17/20). "Press Release: Sigilon Therapeutics Announces $80.3 Million Series B Financing to Advance Shielded Living Therapeutics to the Clinic". Cambridge, MA. |
2020-03-17 |
| BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. |
2020-03-17 |
| Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. |
2020-03-17 |
| CureVac AG. (3/16/20). "Press Release: CureVac Announces Leadership Update". Tübingen & Boston, MA. |
2020-03-16 |
| Fluidigm Corporation. (3/16/20). "Press Release: Consortium of Medical Schools Led by Mount Sinai Fast-Tracking COVID-19 Detection Test Utilizing Fluidigm Microfluidics Technology". South San Francisco, CA. |
2020-03-16 |
| Agilent Technologies Inc.. (3/16/20). "Press Release: Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring". Santa Clara, CA. |
2020-03-16 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech Reports Rapid Progress on COVID-19 Vaccine Program to Address Global Public Health Threat". Mainz. |
2020-03-16 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. |
2020-03-16 |
| dievini Hopp BioTech holding GmbH & Co. KG. (3/15/20). "Press Release: dievini nimmt Stellung zu Presseveröffentlichungen über ihre Beteiligungsgesellschaft". Walldorf. |
2020-03-15 |
| CureVac AG. (3/15/20). "Press Release: CureVac Focuses on the Development of mRNA-based Coronavirus Vaccine to Protect People Worldwide. The Company Rejects Current Rumors of an Acquisition". Tübingen & Boston, MA. |
2020-03-15 |
| Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing". |
2020-03-13 |
| CureVac AG. (3/11/20). "Press Release: Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG". Tübingen & Boston, MA. |
2020-03-11 |
| MedDay Pharmaceuticals S.A.S.. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. |
2020-03-10 |
| Thermo Fisher Scientific Inc.. (3/10/20). "Press Release: Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development". Waltham, MA. |
2020-03-10 |
| Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
| Calixar S.A.S.. (3/9/20). "Press Release: Calixar Launches New Funding Round to Establish Business Strategy". Lyon. |
2020-03-09 |
| MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. |
2020-03-09 |
| UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. |
2020-03-09 |
| Zogenix, Inc.. (3/6/20). "Press Release: Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Emeryville, CA. |
2020-03-06 |
| Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. |
2020-03-05 |
| Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. |
2020-03-05 |
| Biotalys N.V.. (3/5/20). "Press Release: Biotalys Announces Second Closing of €45 Million Series C Financing Round". Ghent. |
2020-03-05 |
| Calyxha Biotechnologies GmbH. (3/4/20). "Press Release: Calyxha Endeavors to Develop Novel Approaches to Tissue Degenerative Diseases and Receives Support from Austrian VC and International Investors". Vienna. |
2020-03-04 |
| Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. |
2020-03-04 |
| Agilent Technologies Inc.. (3/3/20). "Press Release: Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research". Santa Clara, CA. |
2020-03-03 |
| Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. |
2020-03-03 |
| Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. |
2020-03-03 |
| BlueRock Therapeutics. (3/3/20). "Press Release: BlueRock Therapeutics Appoints Seth Ettenberg, Ph.D. Chief Scientific Officer". Cambridge, MA. |
2020-03-03 |
| Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris. |
2020-03-03 |
| Gilead Sciences, Inc.. (3/2/20). "Press Release: Gilead to Acquire Forty Seven for $4.9 Billion". Foster City, CA & Menlo Park, CA. |
2020-03-02 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure Announces 2019 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2020-03-02 |
| Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. |
2020-03-02 |
| Immunocore Ltd.. (3/2/20). "Press Release: Immunocore Secures $130 Million Series B Financing". Oxfordshire & Conshohocken, PA. |
2020-03-02 |
| Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. |
2020-03-02 |
| Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Advanced Liquid Chromatography System Delivers Productivity, Precision and Compliance in Routine Analyses". Germering. |
2020-03-02 |
| MorphoSys AG. (3/2/20). "Press Release: FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants Priority Review for Tafasitamab and Lenalidomide for the Treatment of Relapsed/Refractory DLBCL". Planegg. |
2020-03-02 |
| Thermo Fisher Scientific Inc.. (3/2/20). "Press Release: New Enterprise-Level Chromatography Data System Software Enhances Laboratory Efficiency, Compliance and Standardization". San José, CA. |
2020-03-02 |
| Evonetix Ltd.. (3/2/20). "Press Release: Evonetix Raises $30 Million USD (£23 Million GBP)". Cambridge. |
2020-03-02 |
| CureVac AG. (3/2/20). "Press Release: CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force". Tübingen. |
2020-03-02 |
| Boehringer Ingelheim. (2/28/20). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease". Ingelheim. |
2020-02-28 |
| Cepheid. (2/28/20). "Press Release: Cepheid and Sherlock Biosciences Establish Collaboration on New GeneXpert Tests for Infectious Diseases and Oncology Leveraging CRISPR Technology". Sunnyvale, CA & Cambridge, MA. |
2020-02-28 |
| MGI Tech Co., Ltd.. (2/27/20). "Press Release: MGI and Sophia Genetics Partner to Provide Solutions to Interpret Genomic Data". San José, CA. |
2020-02-27 |
| iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies. |
2020-02-27 |
| Boehringer Ingelheim. (2/27/20). "Press Release: Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform". Ingelheim & San Diego, CA. |
2020-02-27 |
| Twist Bioscience Corporation. (2/26/20). "Press Release: Twist Bioscience and Sophia Genetics Collaborate to Offer Optimized Genomic Solutions". South San Francisco, CA. |
2020-02-26 |
| Nouscom AG. (2/26/20). "Press Release: Nouscom Strengthens Its Management Team. Marina Udier, PhD Appointed as Chief Executive Officer and Patricia Delaite, MD Appointed as Chief Medical Officer". Basel. |
2020-02-26 |
| CRISPR Therapeutics AG. (2/26/20). "Press Release: CRISPR Therapeutics Proposes Changes to the Board of Directors". Zug & Cambridge, MA. |
2020-02-26 |
| CureVac AG. (2/26/20). "Press Release: CureVac Appoints Alan Kimura, MD, PhD as Head of the Newly Created Department “Rare Diseases”". Tübingen & Boston, MA. |
2020-02-26 |
| Thermo Fisher Scientific Inc.. (2/26/20). "Press Release: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper Elected Chairman of the Board of Directors. Director Thomas Lynch Becomes Lead Independent Director". Waltham, MA. |
2020-02-26 |
| Coulter Partners. (2/26/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for Centogene". |
2020-02-26 |
| FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". |
2020-02-25 |
| Bicycle Therapeutics plc. (2/25/20). "Press Release: Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle-based Immuno-oncology Therapies". Cambridge & Boston, MA. |
2020-02-25 |
| Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes. |
2020-02-24 |
| Sophia Genetics S.A.. (2/20/20). "Press Release: Sophia Genetics’ Board of Directors Elects Troy Cox as New Chairman". Lausanne & Boston, MA. |
2020-02-20 |
| Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX. |
2020-02-20 |
| France Biotech. (2/19/20). "Press Release: Driven by Its Successful Debut, the Second Annual International HealthTech Innovation Days Will Take Place in Paris on June 22nd & 23rd". Paris. |
2020-02-19 |
| Tocagen Inc.. (2/19/20). "Press Release: Tocagen and Forte Biosciences Announce Merger. Transaction to Create Nasdaq-listed Company Focused on Advancing Forte's Late-Stage Clinical Program for Atopic Dermatitis". San Diego, CA & Torrance, CA. |
2020-02-19 |
| Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. |
2020-02-18 |
| Cellectis S.A.. (2/18/20). "Press Release: Cellectis and Servier Expand Collaboration on UCART19 Products". New York, NY. |
2020-02-18 |
| Agilent Technologies Inc.. (2/18/20). "Press Release: Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results". Santa Clara, CA. |
2020-02-18 |
| TrakCel Ltd.. (2/17/20). "Press Release: TrakCel Appoints Dr Fiona Withey as Chief Executive Officer". Cardiff. |
2020-02-17 |
| PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. |
2020-02-17 |
| Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. |
2020-02-17 |
| Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel. |
2020-02-17 |
| Domainex Ltd.. (2/13/20). "Press Release: Domainex Announces the Appointment of Tom Mander as Chief Executive Officer". Cambridge. |
2020-02-13 |
| Rentschler Biopharma SE. (2/13/20). "Press Release: Rentschler Biopharma Adds Senior Executive to Growing U.S. Team. Grace Kim Joins as Vice President Business Development – North America and APAC". Laupheim & Milford, MA. |
2020-02-13 |
| Thermo Fisher Scientific Inc.. (2/13/20). "Press Release: Thermo Fisher Scientific Announces Collaboration to Develop Highly Sensitive Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring". San José, CA. |
2020-02-13 |
| Sophia Genetics S.A.. (2/13/20). "Press Release: Sophia Genetics Appoints Chief Medical Officer to Accelerate the Execution of Medical Strategy. Dr. Philippe Menu Joins Sophia Genetics". Lausanne & Boston, MA. |
2020-02-13 |
| Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London. |
2020-02-12 |
| CRISPR Therapeutics AG. (2/12/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results". Zug & Cambridge, MA. |
2020-02-12 |
| Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". |
2020-02-12 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
